SCHEMBL29772276

SCHEMBL29772276

COc1ccc(CNc2ncnc3c2c(Cl)cn3[C@@H]2O[C@H](COc3ccc4ccc(N(C)Cc5ccc(OC)cc5OC)nc4c3)[C@@H](O)[C@@H]2F)c(OC)c1

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 17/20 0.55
▸ METTL3 Q86U44 16/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23313202 1.00 PRMT5 (0.55) PRMT5METTL3
SCHEMBL23273897 0.85 PRMT5 (0.65) PRMT5METTL3
SCHEMBL29772256 0.85 PRMT5 (0.65) PRMT5METTL3
SCHEMBL29772281 0.84 HTR2B (0.51) PRMT5METTL3
SCHEMBL23313210 0.84 HTR2B (0.51) PRMT5METTL3
SCHEMBL23273773 0.79 METTL3 (0.57) PRMT5METTL3
SCHEMBL29772306 0.79 METTL3 (0.57) PRMT5METTL3
SCHEMBL23273841 0.79 PRMT5 (0.45) PRMT5METTL3
SCHEMBL29772268 0.79 PRMT5 (0.45) PRMT5METTL3
SCHEMBL23273984 0.76 METTL3 (0.52) METTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4048674-A2 METTL3 MODULATORS Accent Therapeutics, Inc. (US) 2022-08-31 — — EP disclosed
WO-2021079196-A9 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2022-07-14 — — WO disclosed
Send feedback